Author: BioactiveCompoundLibrary

Upregulation of the TCA cycle leads to an increase in energy generation from the oxidation of acetate, derived from carbohydrates, fat and proteins. As synthesis and degradation of glycogen are vital for embryonic survival during the last phase of incubation, glycogen levels were determined in liver, the most metabolically active tissue of the embryo. Although no significant effects of treatment or an interaction with age could be observed, the albumen-deprived chicks had lower hepatic glycogen content at hatch as compared to both the control and the sham group, suggesting that the released glucose can be distributed to extrahepatic tissue or be used as an energy source in the liver. The variation in glycogen content between individual chicks, however, was very high, but since chicks were randomly selected for sampling, individual chicks may exhibit different hatch times and it is known that time of hatching has an impact on hepatic glycogen content. Reduced liver glycogen content at hatch can be caused by either an increased use of glycogen during the hatching process or a decreased build-up of glycogen before hatch, although the latter is not likely since no differences in glycogen content were detected at ED20. It seems that the albumendeprived chicks had to degrade more of the hepatic glycogen content, needed as energy source during the energy demanding hatching process. Interestingly, several of the affected proteins are involved in glucocorticoid receptor signaling. Glucocorticoid hormones have a central role in the regulation of the glucose metabolism and bind to the GR, which is a transcription factor for regulating gene expression. In sheep, glucocorticoid receptor expression is increased in the liver of neonatal offspring born to ewes which were nutrient restricted during early-mid-gestation. Offspring of rat dams that were protein-restricted throughout gestation had increased glucocorticoid receptor protein and mRNA expression in liver during fetal and postnatal life. The GR was not identified amongst the upregulated proteins, yet may not appear in a 2-D DIGE gel due to its membrane location. However, several proteins involved in GR signaling were upregulated. The level of plasma corticosterone, an important glucocorticoid in birds, however, was not affected in our model. An upregulation of ENO1 and GLUT1 can be associated with increased TR/RXR activation. The thyroid hormone receptor is usually found as a heterodimer with RXR and regulates gene expression. Thyroid hormones are involved in a range of biological processes such as growth, development and metabolism. Plasma thyroid hormone concentrations, both T3 and T4, are reference measurements for evaluating the level of metabolism of the embryos. Plasma T3 concentrations, the biologically active form of thyroid hormone, however, did not differ between groups indicating a decreased metabolism.

Moderate and in some instances, completely failed to activate gene expression. Further analysis found that the activation of an epigenetically silenced gene required a combination of epigenetic modifiers acting together with a TALE activator, while a single TALE was unable to stimulate such a combinatorial effect and was thus inefficient in activating the silenced Oct4 promoter. Recently, two studies have demonstrated that this limitation can be overcome by targeting multiple TALE activators to a gene promoter for synergistic gene activation. Furthermore, these studies reveal that targeting of TALE activators to open chromatin regions within gene promoters are not a requirement for successful gene activation, suggesting that TALEs can override repressive chromatin structures through cooperative binding to a gene promoter. However, some key elements in the promoter regions, such as the TATA-box and transcription initiation site, have not been fully evaluated in the context of TALE technology for gene activation purposes. In eukaryotic cells, initiation of transcription begins with the recognition and binding of promoter-specific transcriptional activators to their cognate DNA response elements within a gene promoter. An activator functions as a platform to recruit and assemble chromatin remodelers and components of the basal transcriptional machinery. More specifically, activators recruit the TATA-box binding protein to gene promoters, resulting in the formation of the preinitiation complex comprised of TBP-associated factors, transcription factor II proteins, and RNA Pol II to stimulate mRNA transcription. Consequently, TBP binding to the TATA box is the rate limiting step in transcriptional initiation. Hence, we rationed that targeted recruitment of TBP using a linked TALE DNA-binding domain to a particular TATA box could lead to transcriptional initiation of the selected gene by bypassing this crucial rate-limiting step. Several studies have shown that artificial recruitment of non-classical activators coupled with classical activators can synergize gene expression. To date, no study has examined the utility of such a strategy using TALE activators for targeted activation of silent gene expression. Therefore, we aimed to interrogate TALE activation potential utilizing the combined action of chimeric TBP and VP64-TALE activators applied to a classical example of gene silencing observed within T-cell biology illustrated by IL-2 and GM-CSF genes. Our data shows that TALE fused to TBP acts synergistically with other VP64-TALE activators and this combination is significantly more efficacious than multiple TALE activators alone in activating expression of IL-2 and GM-CSF in diverse non-immune cells in which both genes are otherwise completely silenced. Chromatin analysis revealed that the gene activation was due in part to displacement of a distinctly positioned nucleosome.

Whether diet specific epigenetic changes can also be detected in circulating blood leukocytes or contribute to disease progression is a hot research topic. The correlation of genome-wide data on DNA methylation and gene expression unveiled that methylation of promoter regions is frequently associated with transcriptional repression of genes being under control of this promoter. On the other hand it was also observed that this simple relation is not universally applicable but rather depends on genes, cell types, tissues and genetic variants. The majority of these findings are derived from in vitro experiments with cell cultures. However, data that directly link DNA methylation changes with alterations in gene expression in humans are scarce. A first randomized controlled clinical study recently reported that the controlled intake of a cocoa extract by humans at cardiovascular risk is able to affect both global DNA methylation of white blood cells, as well as the expression of individual genes involved in the regulation of DNA methylation. Whether transcriptional changes induced by the regular consumption of dietary polyphenols on a whole genome level can be related to changes of the methylome in white blood cells has yet not been investigated. Taken together, it can be hypothesized that dietary flavanols are able to modulate the expression of genes being associated with CVD pathomechanisms via changes in the DNA methylation pattern of these genes. The present study aimed at investigating the impact of an 8 weeks controlled dietary intervention with MOF in smokers, i.e. humans with an increased risk of CVD, on genome-wide changes in leukocytes’ gene expression and relate them to changes in DNA methylation. In animal models and in vitro studies, the potential beneficial effect of flavanols on the prevention of different diseases including cancer, neurodegenerative and cardiovascular diseases has been demonstrated. This effect seems to be related to their capacity to modulate the activity of different enzymes, cell signalling proteins and expression of genes and proteins. A recent metaanalysis has revealed that grape seed extract appears to significantly lower systolic blood pressure and heart rate, and we have recently shown that consumption of grape seedderived MOF presented an overall vascular health benefit. The potential mechanism of action underlying these effects in humans is still largely unknown. The capacity of polyphenols to modulate gene expression profiles in circulating blood cells in humans has been described in a few clinical trials. These nutrigenomics studies have shown that hesperidin, quercetin, resveratrol or isoflavones can modulate the expression of 560 to over 4000 genes suggesting that the health benefits of polyphenols in humans is probably dependent on their genomic effects.

Similar to human measles clinical findings in canine distemper virus -infected dogs include fever, rash, respiratory signs, and lymphopenia. Affected animals are prone to opportunistic infections as a consequence of generalized lymphoid depletion and profound immunosuppression. Moreover, persistent infection of peripheral lymphoid organs and the central nervous system of carnivores leads to long lasting immune alterations and immune mediated neuropathology. Dendritic cells represent the most potent antigen presenting cell population, which initiate primary T cell responses and play an important role also for B cell immunity. Several pathogens, including human herpesvirus type-1 as well as human and feline immunodeficiency viruses, target DCs and have evolved strategies to modulate their cytokine expression and antigen presenting capacity, thereby promoting virus immune evasion and persistence. Other mechanisms include alteration of endocytosis, vesicle trafficking, and immunological synapse formation or apoptosis induction of infected DCs. A disturbed function of antigen presenting cells, including DCs, is supposed to contribute to immunosuppression in measles patients. Moreover, following infection of the respiratory tract, MV-infected DCs might mediate virus transmission to secondary lymphoid organs. During the chronic disease stage of canine distemper, cells with a DC-like morphology seem to serve as the primary host cells for the virus, which might promote viral persistence in lymphoid organs. Thus, an inhibited terminal differentiation of DCs is currently discussed to be responsible for diminished antigen presenting function and disturbed repopulation of lymphoid tissues in CDV-infected dogs, as suggested for MV-infection. In addition, CDV-infection of thymic DCs may result in compromised T cell maturation, promoting the release of immature, potentially autoreactive lymphocytes, demonstrating a potential participation of DCs in both CDV-induced immunosuppression and immunopathology. However, whether CDV has the ability to infect canine DCs and direct viral effects upon these professional antigen presenting cells have not yet been confirmed. The aim of the present study was to determine the permissiveness of canine DCs to CDV in vitro. Besides antigen presentation via the major histocompatibility complex, adequate T cell activation by DCs requires co-stimulation by molecules such as CD80 and CD86. An additional signal is mediated by DC-released cytokines leading to T cell polarization. Thus, in order to testify the hypothesis that infection leads to an impaired T cell stimulatory capacity of these cells, the impact of CDV upon molecules involved in antigen presentation and co-stimulation and the associated cytokine expression was investigated. The present study demonstrates the ability of CDV to infect canine DCs and to modulate their antigen presenting properties and cytokine expression.

lt brain compared to 20% and 100% for newborn and AD brain respectively, indicating that adult tau protein is not extensively phosphorylated. Furthermore, developmental studies in rodents have shown that while some epitopes, such as pT205 or pT181, are highly phosphorylated in the post-embryonic brain, their signal is very faint in adult brain, which could explain why AT8 and AT270 are more prone to display non-specific Igs signal. On the other hand, epitopes such as pS202 or pS396 and pS404 are abundant in the adult brain, and do not display overt non-specific signal in our experiments. We were surprised to see a non-specific signal around 37 kD with the MC1 antibody in Tau KO mice. This antibody recognizes an abnormal conformation of tau encompassing amino acids 5–15 and 312–322. We think that this non-specific signal is due to the knock-in of the EGFP coding sequence into the first exon disrupting the expression of the Mapt gene, and resulting in a chimeric protein with EGFP fused to the first 31 amino acids of tau. Indeed, the same band was detected with an anti-GFP antibody and disappeared in the HS fraction. These results indicate that, somehow, the fusion of EGFP to the small sequence of tau was able to mimic the MC1 epitope. To help improve the detection of tau signal, we first used secondary antibodies designed to bind native Igs. Because Igs coming from the samples are denatured, these antibodies recognize only the primary antibodies, and eliminate the interference of Igs heavy and light chains during the Western blot procedure. Indeed, TrueBlot antibodies completely removed the non-specific signal from problematic primary antibodies in TKO, WT and 3xTg mice, allowing for the visualization of tau signal without interference. The use of TrueBlot antibodies did not necessitate an important modification of the standard Western blot procedure as they replaced conventional secondary antibodies. However, we observed that it was sometimes difficult to obtain a signal with TrueBlot secondary antibodies; hence, we had to increase the amount of protein being loaded or alter their incubation time from 1 h at room temperature for standard secondary antibodies to overnight or more at 4uC with TrueBlot. As an alternative to TrueBlot, we also tested secondary antibodies designed to bind the light chain of Igs at 25 kDa and do not recognize the heavy chain at 50 kDa. These antibodies recognize only the primary antibodies and the light chain of Igs on the membrane, and eliminate the interference of Igs heavy chains in Western blot procedure. Indeed, anti-LC antibodies completely removed the non-specific signal from problematic primary antibodies in TKO, WT and 3xTg mice, allowing a visualization of tau signal without interference. Furthermore, the use of LC antibodies has several advantages versus TrueBlot antibodies: they are less expensive, can be diluted more, and incubated at room temperature for 1 h.